Previous studies have shown that the type I interferon-IRF7 axis can mediate the transcription of the USP25 gene after viral infection or lipopolysaccharide treatment (31) and that miRNA-200c can reduce both the messenger RNA and protein levels of USP25 in non-small cell lung cancer (32). The gene discussed is IRF7; the disease is viral infectious disease.